Cargando…

CPMS–improving patient care in Europe via virtual case discussions

PURPOSE: The core task of European Reference Networks (ERNs) is to reduce health care inequalities throughout Europe for all patients with rare and complex conditions. A secure web-based application for virtual consultations, the Clinical Patient Management System (CPMS), was developed by the EU to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mönig, Isabel, Steenvoorden, Danielle, de Graaf, Johan P., Ahmed, S. Faisal, Taruscio, Domenica, Beun, Johan G., Johannsen, Trine H., Juul, Anders, Hiort, Olaf, Pereira, Alberto M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851636/ https://www.ncbi.nlm.nih.gov/pubmed/33528763 http://dx.doi.org/10.1007/s12020-021-02628-x

Ejemplares similares

A critical evaluation of the EU-virtual consultation platform (CPMS) within the European Reference Network on Rare Endocrine Conditions
por: White, E K, et al.
Publicado: (2022)

Pubertal development in 46,XY patients with NR5A1 mutations
por: Mönig, Isabel, et al.
Publicado: (2021)

Genetic testing in inherited endocrine disorders: joint position paper of the European reference network on rare endocrine conditions (Endo-ERN)
por: Eggermann, Thomas, et al.
Publicado: (2020)

Shaping national plans and strategies for rare diseases in Europe: past, present, and future
por: Hedley, Victoria, et al.
Publicado: (2021)

Digital health and Clinical Patient Management System (CPMS) platform utility for data sharing of neuromuscular patients: the Italian EURO-NMD experience
por: Fortunato, Fernanda, et al.
Publicado: (2023)

Differential gene expression among three sex types reveals a MALE STERILITY 1 (CpMS1) for sex differentiation in papaya
por: Zerpa-Catanho, Dessireé, et al.
Publicado: (2019)

Patients with rare endocrine conditions have corresponding views on unmet needs in clinical research
por: de Graaf, Johan P., et al.
Publicado: (2021)

Access to patient oriented information—a baseline Endo-ERN survey among patients with rare endocrine disorders
por: Iotova, Violeta, et al.
Publicado: (2021)

The EuRRECa Project as a Model for Data Access and Governance Policies for Rare Disease Registries That Collect Clinical Outcomes
por: Ali, Salma R., et al.
Publicado: (2020)

The Application of Principal Component Analysis on Clinical and Biochemical Parameters Exemplified in Children With Congenital Adrenal Hyperplasia
por: Ljubicic, Marie Lindhardt, et al.
Publicado: (2021)

Current models of care for disorders of sex development – results from an International survey of specialist centres
por: Kyriakou, Andreas, et al.
Publicado: (2016)

SUN-070 European Registries for Rare Endocrine Conditions (EuRRECa): Results from the Platform for E-reporting of Rare Endocrine Conditions (e-REC)
por: Ali, Salma R, et al.
Publicado: (2020)

Introduction to Endo-ERN–scope and mission
por: Pereira, Alberto M., et al.
Publicado: (2021)

Discussions on future high-energy accelerators in Europe
por: E. H. S. BURHOP
Publicado: (1964)

Synopsis of the Discussions of the American Dental Society of Europe
por: Wright, C. M.
Publicado: (1874)

European Project for Rare Diseases National Plans Development (EUROPLAN)
por: Taruscio, Domenica, et al.
Publicado: (2010)

Multifactorial Rare Diseases: Can Uncertainty Analysis Bring Added Value to the Search for Risk Factors and Etiopathogenesis?
por: Taruscio, Domenica, et al.
Publicado: (2021)

Significant gender difference in serum levels of fibroblast growth factor 21 in Danish children and adolescents
por: Bisgaard, Amalie, et al.
Publicado: (2014)

Understanding the needs of professionals who provide psychosocial care for children and adults with disorders of sex development
por: Dessens, Arianne, et al.
Publicado: (2017)

The differential role of androgens in early human sex development
por: Hiort, Olaf
Publicado: (2013)

Starting point for benchmarking outcomes and reporting of pituitary adenoma surgery within the European Reference Network on Rare Endocrine Conditions (Endo-ERN): results from a meta-analysis and survey study
por: Zamanipoor Najafabadi, Amir H, et al.
Publicado: (2022)

Serum Concentrations and Gonadal Expression of INSL3 in Eighteen Males With 45,X/46,XY Mosaicism
por: Ljubicic, Marie Lindhardt, et al.
Publicado: (2021)

The current landscape of European registries for rare endocrine conditions
por: Ali, S R, et al.
Publicado: (2018)

An Approach to Asynchronous Virtual Scientific Paper Discussions
por: Debbink, Kari
Publicado: (2021)

The Role of microRNAs in the Biology of Rare Diseases
por: Salvatore, Marco, et al.
Publicado: (2011)

Modeling delay to diagnosis for Amyotrophic lateral sclerosis: under reporting and incidence estimates
por: Rocchetti, Irene, et al.
Publicado: (2012)

COVID-19 and the rare disease organization response during pandemic: the ‘Italian model’
por: Taruscio, Domenica, et al.
Publicado: (2022)

The Quality Evaluation of Rare Disease Registries—An Assessment of the Essential Features of a Disease Registry
por: Ali, Salma Rashid, et al.
Publicado: (2021)

Leaders come to Imperial to discuss the future of Europes research facilities
Publicado: (2009)

Protocols.io: Virtual Communities for Protocol Development and Discussion
por: Teytelman, Leonid, et al.
Publicado: (2016)

The use of virtual slides in the EUROPALS examination
por: van den Tweel, Jan G, et al.
Publicado: (2011)

Discussion of Miller’s Theory at the Last Meeting of the American Dental Society, of Europe
Publicado: (1885)

Personalised Medicine—Implementation to the Healthcare System in Europe (Focus Group Discussions)
por: Stefanicka-Wojtas, Dorota, et al.
Publicado: (2023)

The current use of glaucoma virtual clinics in Europe
por: Azzopardi, Matthew, et al.
Publicado: (2022)

ENDO-ERN ON RARE ENDOCRINE CONDITIONS: Endo-ERN in its fifth year: a pinch of care, science, curiosity and new horizons
por: Iotova, Violeta, et al.
Publicado: (2022)

New NR5A1 mutations and phenotypic variations of gonadal dysgenesis
por: Werner, Ralf, et al.
Publicado: (2017)

The Occurrence of 275 Rare Diseases and 47 Rare Disease Groups in Italy. Results from the National Registry of Rare Diseases
por: Taruscio, Domenica, et al.
Publicado: (2018)

Reflections on the Importance of Cost of Illness Analysis in Rare Diseases: A Proposal
por: Armeni, Patrizio, et al.
Publicado: (2021)

Social/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe
por: Angelis, Aris, et al.
Publicado: (2016)

Anti-Müllerian Hormone and Its Clinical Use in Pediatrics with Special Emphasis on Disorders of Sex Development
por: Lindhardt Johansen, Marie, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_bp9q8oid62olh70lm20pgfk5jt